1 jection, most cardiac and other organ grafts
eventually succumb to chronic vasculopathy, interstitial
2 Such transformed cells
eventually succumb to crisis, a period of widespread cel
3 SV40T (BMSVTs) had an extended lifespan, but
eventually succumbed to crisis.
4 However, these mice
eventually succumbed to cystic kidney disease despite mT
5 indolent, WM is incurable and most patients
eventually succumb to disease progression.
6 Treated mice
eventually succumb to disease, thus, targeting the Hedge
7 nts relapse following standard treatment and
eventually succumb to disease.
8 ; patients often develop drug resistance and
eventually succumb to disease.
9 ity waned with time, and the treated animals
eventually succumbed to hepatic tumor relapse or distant
10 no further clinical effect, and the patient
eventually succumbed to his condition.
11 ice initially controlled parasite growth but
eventually succumbed to infection.
12 rolonged survival, the reconstituted animals
eventually succumbed to infection.
13 ompromised mice: many micro MT and RAG1 mice
eventually succumbed to infection.
14 immunity was required because most SCID mice
eventually succumbed to local tumor recurrence even with
15 s mutants survive into early adulthood, they
eventually succumb to massive intracardiac thrombosis.
16 e (L-NMMA), a large proportion of these mice
eventually succumbed to opportunistic infections, but no
17 are usually not sustained, and most patients
eventually succumb to progressive disease, indicating th
18 is subverted in the majority of patients who
eventually succumb to progressive disease.
19 and regained bowel function, but 2 patients
eventually succumbed to progressive peritoneal disease.
20 rowth in systemic tissues to occur, and mice
eventually succumbed to relapsing infection.
21 Patients
eventually succumb to renal, cardio-, or cerebrovascular
22 All antimalarial drugs developed so far have
eventually succumbed to resistance.
23 variable, but approximately 20% of patients
eventually succumb to the cepacia syndrome, which is cha
24 duals that survive initial ASF infection but
eventually succumb to the disease are key for the long-t
25 , the majority of stage IV melanoma patients
eventually succumb to the disease.
26 val, nearly all patients with advanced ccRCC
eventually succumb to the disease.
27 tatic ccRCC, although virtually all patients
eventually succumb to the disease.
28 s a plasma cell malignancy and most patients
eventually succumb to the disease.
29 dividuals will develop recurrent BC and will
eventually succumb to the disease.
30 t to grow and differentiate in the tail, but
eventually succumb to the resorption program.
31 However, all treated mice
eventually succumb to the tumors.
32 e myeloid leukemia (AML) two years later and
eventually succumbed to the disease.
33 most women diagnosed with late-stage disease
eventually succumb to their cancer.
34 in lymphoma, yet 40% to 50% of patients will
eventually succumb to their disease, demonstrating a pre
35 after definitive locoregional treatment and
eventually succumb to their disease.
36 al malignancies, with virtually all patients
eventually succumbing to their disease.
37 ce displayed enhanced resistance though they
eventually succumbed to this infection.
38 CY plus IL-2-treated self-Ag-expressing mice
eventually succumb to tolerization, this delay results i
39 ell as acute resistance; however, these mice
eventually succumbed to toxoplasmic encephalitis, despit
40 Flt3L alone showed delayed tumor growth but
eventually succumbed to tumor progression.
41 r the host successfully rejects the tumor or
eventually succumbs to tumor outgrowth.